OcellO

OcellO news

First in human for MCLA-158!

MCLA-158 is a bispecific antibody created by Merus – one of a library of antibodies that was identified by OcellO in screens of colorectal cancer organoids derived by the HUB (Hubrecht Organoid Technology). This work was carried out under the suppresSTEM consortium, funded by the EU.

See the full press release here

Meet us at SLAS Europe meeting, Brussel, Belgium, 27-29 June 2018

Kuan Yan and Sander Basten will be attending SLAS Europe 2018

On 29 June in the “Track 2 TECHNOLOGY: Next Generation Analytics”, Kuan will be presenting lecture titled

“Image-based quantification of immunotherapies effects in 3D environment”

Feel free to contact us for a meeting via info@ocello.nl

More information about the conference, click here

For detail programme, click here

Post expires at 8:00pm on Thursday June 28th, 2018

Meet us at the Dechema 3D Cell Culture, Freiburg, Germany, 5-7 June 2018

 

Our team will represent OcellO in the exhibition hall, Booth D2, ready to meet you and showcase OcellO’s technology.

Please come and meet us during the conference!

 

In addition, we will be presenting the following:

 

Posters:

A 3D High-Content Screening assay as model system for polycystic kidney disease. Bange, T.H. Booij, W.H. Leonhard, K. Yan, D.J.M. Peters, L.S. Price

High content screening of intestinal organoid cultures to visualize and quantify immune responses. Madej, B. Herpers, L. Salinaro, K. Yan, L. Daszkiewicz, L.S. Price

Patient-derived 3D tumor cultures for clinical diagnostics and pre-clinical drug development. Basten, B. Herpers, K. Yan, T. Giesemann, J. Schueler, W. Vader, L.S. Price

Oral presentation:

Image-based quantification of immunotherapies effects in 3D environment. K. Yan, L. Daszkiewicz, L.S. Price

Feel free to contact us for a meeting via info@ocello.nl.
More information about the conference, click here

Post expires at 2:27pm on Saturday June 9th, 2018

Meet us at the AACR Annual meeting 2018 “Driving Innovative Cancer Science to Patient Care”, Chicago, USA, 14-18 April 2018

More information about the conferenceclick here

We will be presenting the following posters:

A 3D image-based quantification of T cell-mediated killing of CRC organoids in the presence of immuno-modulators.

Patient-derived 3D tumor cultures for clinical diagnostics and pre-clinical drug development.

Targeting the WNT-pathway in 3D-cultures of pancreatic cancer biopsies.